Separately, Hindustan Zinc informed the exchanges that it has signed a memorandum of understanding (MoU) with Sulfozyme Agro under its flagship Zinc Industrial Park initiative at Khankhala, Rajasthan
DEE Development Engineers shares have surged as much as 285 per cent from their 52-week low of ₹183, touched earlier this year on January 27, 2026 on the NSE
Analysts Deepika Murarka and Stuti Bagadia expect JSLL to deliver revenue, Ebitda and PAT CAGR of 33.6 per cent, 34.9 per cent and 41.6 per cent, respectively, over FY26-FY29E
The company reported a more than two-fold increase in profit after tax (PAT) to ₹50.60 crore in the March quarter of FY26, compared with ₹24.31 crore in the Q4FY25
Along with its quarterly results, the board recommended a dividend of ₹1.50 per equity share of face value ₹1 each, fully paid up, for the financial year ended March 31, 2026
Jupiter Tatravagonka Railwheel Factory Pvt. Ltd. (JTRWF) has entered into a definitive long-term supply agreement with European rail wagon manufacturer Tatravagonka a.s.
ACME Solar Holdings shares have bounced nearly 58 per cent from their 52-week low of ₹309.15 per share touched earlier this year on March 27, 2026, on the NSE
IRFC has signed a ₹13,527 crore term loan agreement with L&T Metro Rail (Hyderabad) Limited (L&TMRHL) to refinance the debt obligations of the Hyderabad Metro Rail project
The company reported revenue growth of 174.5 per cent in Q4FY26 over the corresponding quarter last year, posting its highest-ever quarterly revenue of ₹715.5 crore
The company also announced that its board has declared a dividend of ₹5 per equity share of face value ₹10 each, amounting to 50 per cent for the financial year 2025-26
Apollo Hospitals Enterprise's board has recommended a final dividend of ₹10 per equity share (200 per cent) of face value of ₹5 per share for FY2025-26
The sentiment was further supported by positive commentary from brokerages including MOFSL and Choice, who reaffirmed their 'Buy' ratings on Grasim Industries
Management said there remains potential upside to the guidance, depending on the pace of approvals, registrations, and commercialisation across key international markets